TrialBritish journal of pharmacology2021

Early or deferred initiation of efavirenz during rifampicin-based TB therapy has no significant effect on CYP3A induction in TB-HIV infected patients.

Eleni Aklillu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.